DK2175877T3 - Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme - Google Patents
Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdommeInfo
- Publication number
- DK2175877T3 DK2175877T3 DK08786266.0T DK08786266T DK2175877T3 DK 2175877 T3 DK2175877 T3 DK 2175877T3 DK 08786266 T DK08786266 T DK 08786266T DK 2175877 T3 DK2175877 T3 DK 2175877T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- coagulation disorders
- mutated antithrombin
- antithrombin
- Prior art date
Links
- 206010053567 Coagulopathies Diseases 0.000 title abstract 2
- 239000004019 antithrombin Substances 0.000 title abstract 2
- 208000015294 blood coagulation disease Diseases 0.000 title abstract 2
- 230000009852 coagulant defect Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8128—Antithrombin III
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290913 | 2007-07-20 | ||
| PCT/EP2008/059486 WO2009013251A1 (en) | 2007-07-20 | 2008-07-18 | Use of mutated antithrombins for treating or preventing coagulation disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2175877T3 true DK2175877T3 (da) | 2012-04-16 |
Family
ID=39111552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08786266.0T DK2175877T3 (da) | 2007-07-20 | 2008-07-18 | Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8741844B2 (da) |
| EP (1) | EP2175877B1 (da) |
| JP (1) | JP2010533684A (da) |
| AT (1) | ATE539764T1 (da) |
| CA (1) | CA2694047C (da) |
| DK (1) | DK2175877T3 (da) |
| WO (1) | WO2009013251A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010081878A1 (en) * | 2009-01-16 | 2010-07-22 | Universite Paris-Sud Xi | Mutated antithrombins, a process for preparing the same and their use as drugs |
| US20140356377A1 (en) * | 2011-08-25 | 2014-12-04 | Umc Utrecht Holding B.V. | Compounds for use in boosting coagulation |
| US9127274B2 (en) * | 2012-04-26 | 2015-09-08 | Alnylam Pharmaceuticals, Inc. | Serpinc1 iRNA compositions and methods of use thereof |
| PE20160533A1 (es) | 2013-03-14 | 2016-06-09 | Bayer Healthcare Llc | Anticuerpos monoclonales contra antitrombina beta que forma complejos con heparina |
| GB201322091D0 (en) | 2013-12-13 | 2014-01-29 | Cambridge Entpr Ltd | Modified serpins for the treatment of bleeding disorders |
| WO2016069694A2 (en) | 2014-10-30 | 2016-05-06 | Alnylam Pharmaceuticals, Inc. | Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof |
| KR20210157474A (ko) | 2015-12-07 | 2021-12-28 | 젠자임 코포레이션 | Serpinc1-연관 장애의 치료를 위한 방법 및 조성물 |
| ES2992695B2 (es) * | 2023-06-15 | 2025-07-23 | Fundacion Para La Formacion E Investig Sanitarias De La Region De Murcia [Ffiis | Antidoto |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3901917A1 (de) * | 1989-01-24 | 1990-07-26 | Behringwerke Ag | Mutanten von humanem antithrombin iii |
| JP3479539B2 (ja) * | 1992-04-10 | 2003-12-15 | エーザイ株式会社 | ヒトアンチトロンビンｉｉｉ変異体 |
| JPH0971600A (ja) * | 1995-09-06 | 1997-03-18 | Eisai Co Ltd | ヒトアンチトロンビンｉｉｉ 変異体 |
| ES2299425T3 (es) * | 1999-05-13 | 2008-06-01 | Gtc Biotherapeutics, Inc. | Antitrombina iii producida geneticamente y formas mutantes de la misma. |
| US20060198836A1 (en) * | 2003-07-17 | 2006-09-07 | Smithkline Beecham Corporation | Method of treating hit patients with argatroban |
-
2008
- 2008-07-18 JP JP2010516522A patent/JP2010533684A/ja active Pending
- 2008-07-18 DK DK08786266.0T patent/DK2175877T3/da active
- 2008-07-18 US US12/669,855 patent/US8741844B2/en not_active Expired - Fee Related
- 2008-07-18 CA CA2694047A patent/CA2694047C/en not_active Expired - Fee Related
- 2008-07-18 EP EP08786266A patent/EP2175877B1/en not_active Not-in-force
- 2008-07-18 WO PCT/EP2008/059486 patent/WO2009013251A1/en not_active Ceased
- 2008-07-18 AT AT08786266T patent/ATE539764T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| US8741844B2 (en) | 2014-06-03 |
| EP2175877A1 (en) | 2010-04-21 |
| ATE539764T1 (de) | 2012-01-15 |
| CA2694047A1 (en) | 2009-01-29 |
| WO2009013251A1 (en) | 2009-01-29 |
| CA2694047C (en) | 2018-01-30 |
| EP2175877B1 (en) | 2012-01-04 |
| JP2010533684A (ja) | 2010-10-28 |
| US20100298224A1 (en) | 2010-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2175877T3 (da) | Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme | |
| ES2352576T8 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana. | |
| DK2375907T3 (da) | Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller | |
| CY1121203T1 (el) | Θεραπευτικες χρησεις της εμπαγλιφλοζινης | |
| CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
| AU2018253580A1 (en) | Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level | |
| WO2009108856A3 (en) | Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof | |
| AU2011274619A8 (en) | miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway | |
| GT201400033A (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
| AU2012205878A8 (en) | miRNA for treating diseases and conditions associated with neo-angiogenesis | |
| EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| CU20090148A7 (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
| HRP20181727T1 (hr) | Upotreba protutijela protiv čimbenika xi, namijenjena sprečavanju ili liječenju stvaranja krvnog ugruška | |
| MX356210B (es) | Formulaciones de polimero acrilico. | |
| EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| PL3689346T3 (pl) | 3,6-Dipodstawione sole ksantyliowe do leczenia tauopatii | |
| IT1395519B1 (it) | Pezzo composito, nonche' impiego del pezzo composito | |
| IN2012DN02471A (da) | ||
| EA201600442A1 (ru) | Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол | |
| JO2581B1 (en) | Substituted Arylsulfonamides | |
| CR20110552A (es) | Tratamiento de transtornos resistentes a la insulina | |
| ECSP099807A (es) | (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea | |
| MX347620B (es) | Derivados de sulfonilaminopirrolidinona, su preparacion y aplicacion terapeutica. | |
| PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso |